{
    "title": "AstraZeneca says its Oxford vaccine deal allows it to add up to 20% of manufacturing costs",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8874155/AstraZeneca-says-Oxford-vaccine-deal-allows-add-20-manufacturing-costs.html",
    "date": "2020-10-23",
    "keywords": [
        "vaccine",
        "company",
        "manufacturing",
        "astrazeneca",
        "friday",
        "oxford",
        "university",
        "statement",
        "trial",
        "approval",
        "supply",
        "covid19",
        "plc",
        "coronavirus",
        "deal",
        "drugmaker",
        "addition",
        "excess",
        "development",
        "distribution",
        "pharmacovigilance",
        "spokesman",
        "amount",
        "equivalent",
        "maximum",
        "impact",
        "year",
        "profit",
        "supplyandmanufacture",
        "latestage",
        "april",
        "pharma",
        "access",
        "pricing",
        "funding",
        "protection",
        "liability",
        "reporting",
        "kanishka",
        "singh",
        "mccool"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}